Tools | Bookmark & Share | Make MrWhy My Homepage
MrWhy.com
Go
Total Results: 593 Videos
MrWhy.com » Videos » Www.Ecancer.Tv - Science -
Page: 10 of 30Previous Page67891011121314Next Page
Dr Paul Cornes,  Bristol Oncology Centre, UK Dr Paul Cornes, Bristol Oncology Centre, UK
Channel: www.ecancer.tv
Length: 0
Date: August 03, 2010
Dr Cornes speaks about an e-learning facility used to share information among oncologists in Asia. Experts give lessons in the radiotherapy best pr...
Dr Paul Cornes,  Bristol Oncology Centre, UK Dr Paul Cornes, Bristol Oncology Centre, UK
Channel: www.ecancer.tv
Length: 0
Date: August 03, 2010
Dr Cornes discusses how the health service will cope with the costs associated with rapidly rising cancer rates. Dr Cornes speaks about the role cl...
Dr Stephen Baylin,  The Sidney Kimmel Comprehensive Cancer Center, Baltimore, USA Dr Stephen Baylin, The Sidney Kimmel Comprehensive Cancer Center, Baltimore, USA
Channel: www.ecancer.tv
Length: 0
Date: August 03, 2010
Dr Stephen Baylin speaks at an EHA 2010 press conference about the use of epigenetics to treat cancer. Dr Baylin explains what epigenetics is, tal...
Prof Gilles Salles,  Centre Hospitalier Lyon-Sud, France Prof Gilles Salles, Centre Hospitalier Lyon-Sud, France
Channel: www.ecancer.tv
Length: 0
Date: August 03, 2010
Prof Gilles Salles speaks at an EHA 2010 press conference about the PRIMA study which has shown that retuximab 'maintenance' ther...
Dr Michael Huo,  University of Texas Southwestern Medical Center, USA Dr Michael Huo, University of Texas Southwestern Medical Center, USA
Channel: www.ecancer.tv
Length: 0
Date: August 03, 2010
Dr Michael Huo speaks at an EHA 2010 press conference about a phase III prospective study comparing the dabigatran etexilate 220mg with enoxaparin ...
Prof Robin Foà,  Sapienza University of Rome, Italy Prof Robin Foà, Sapienza University of Rome, Italy
Channel: www.ecancer.tv
Length: 0
Date: August 03, 2010
Prof Robin Foà talks about the increasing importance of the annual EHA congress, not just within Europe but across the world. The 2010 Barcelona c...
Dr Siow Ming Lee,  University College London, UK Dr Siow Ming Lee, University College London, UK
Channel: www.ecancer.tv
Length: 0
Date: August 03, 2010
Dr Lee speaks about the TOPICAL trial, a randomised phase III trial of erlotinib in chemotherapy-naive patients with advanced non-small cell lung ...
Dr Rachel Iredale,  Prof Lesley Fallowfield, Carol Maddock, Maureen Gilbert, Cathie Lockenwitz, Francisca Bach Kolling – Dandrieu and Roswitha Britz Dr Rachel Iredale, Prof Lesley Fallowfield, Carol Maddock, Maureen Gilbert, Cathie Lockenwitz, Francisca Bach Kolling – Dandrieu and Roswitha Britz
Channel: www.ecancer.tv
Length: 0
Date: July 26, 2010
At the time of your diagnosis did you feel you had sufficient information to make informed decisions?Would it have been helpful to have been given ...
Dr Rachel Iredale,  Prof Lesley Fallowfield, Carol Maddock, Maureen Gilbert, Cathie Lockenwitz, Francisca Bach Kolling – Dandrieu and Roswitha Britz Dr Rachel Iredale, Prof Lesley Fallowfield, Carol Maddock, Maureen Gilbert, Cathie Lockenwitz, Francisca Bach Kolling – Dandrieu and Roswitha Britz
Channel: www.ecancer.tv
Length: 0
Date: July 26, 2010
What are the implications of knowing you are a gene carrier and how can you be better supported?For the women in these clips, discovering that the...
Dr Rachel Iredale,  Prof Lesley Fallowfield, Carol Maddock, Maureen Gilbert, Cathie Lockenwitz, Francisca Bach Kolling – Dandrieu and Roswitha Britz Dr Rachel Iredale, Prof Lesley Fallowfield, Carol Maddock, Maureen Gilbert, Cathie Lockenwitz, Francisca Bach Kolling – Dandrieu and Roswitha Britz
Channel: www.ecancer.tv
Length: 0
Date: July 26, 2010
If you had to pick one thing that you think would improve risk communication what would it be? How can we speed up the process of adoption of best ...
Dr Rachel Iredale,  Prof Lesley Fallowfield, Carol Maddock, Maureen Gilbert, Cathie Lockenwitz, Francisca Bach Kolling – Dandrieu and Roswitha Britz Dr Rachel Iredale, Prof Lesley Fallowfield, Carol Maddock, Maureen Gilbert, Cathie Lockenwitz, Francisca Bach Kolling – Dandrieu and Roswitha Britz
Channel: www.ecancer.tv
Length: 0
Date: July 26, 2010
Who are the health professionals generally involved in communicating genetic risk in your country? Does it vary and are they the right people?What ...
Dr Rachel Iredale,  Prof Lesley Fallowfield, Carol Maddock, Maureen Gilbert, Cathie Lockenwitz, Francisca Bach Kolling – Dandrieu and Roswitha Britz Dr Rachel Iredale, Prof Lesley Fallowfield, Carol Maddock, Maureen Gilbert, Cathie Lockenwitz, Francisca Bach Kolling – Dandrieu and Roswitha Britz
Channel: www.ecancer.tv
Length: 0
Date: July 26, 2010
What advice or support about how to tell other members of your family about being a gene carrier were you given? What works well?
Prof Tony Goldstone,  Imperial College London, UK Prof Tony Goldstone, Imperial College London, UK
Channel: www.ecancer.tv
Length: 0
Date: July 26, 2010
Prof Goldstone talks about the UKALL trials investigating treatment options for patients with ALL. These trials have compared allograft, the use o...
Dr Steve Johnson Dr Steve Johnson
Channel: www.ecancer.tv
Length: 0
Date: July 26, 2010
Dr Johnson talks about the communication skills workshop he chaired at EHA 2010 and explains how good communication skills benefit both clinicians ...
Prof Stephen O’Brien,  Newcastle University UK Prof Stephen O’Brien, Newcastle University UK
Channel: www.ecancer.tv
Length: 0
Date: July 26, 2010
Prof O’Brien discusses the idea he proposed at the 2010 EHA congress: 'Patients should be 'forced' to enter clinical tri...
Professor Robert Coleman,  Weston Park Hospital, Sheffield, UK Professor Robert Coleman, Weston Park Hospital, Sheffield, UK
Channel: www.ecancer.tv
Length: 0
Date: July 23, 2010
Professor Robert Coleman speaks about the side effects experienced by patients with cancer of the bone and discusses how denosumab, zoledronic aci...
Professor Robert Coleman,  Weston Park Hospital, Sheffield, UK Professor Robert Coleman, Weston Park Hospital, Sheffield, UK
Channel: www.ecancer.tv
Length: 0
Date: July 23, 2010
Professor Robert Coleman talks about zoledronic acid, other bisphosphonates and denosumab, the mechanism through which these drugs affect cancers ...
Professor Robert Coleman,  Weston Park Hospital, Sheffield, UK Professor Robert Coleman, Weston Park Hospital, Sheffield, UK
Channel: www.ecancer.tv
Length: 0
Date: July 23, 2010
Peter Goodwin speaks to Professor Robert Coleman about targeted therapy, specifically treatment that targets bone metastases. Prof Coleman explain...
Professor Jesús San-Miguel - University Hospital of Salamanca,  Spain Professor Jesús San-Miguel - University Hospital of Salamanca, Spain
Channel: www.ecancer.tv
Length: 0
Date: July 23, 2010
Prof Jesús San-Miguel talks about the progression in myeloma survival rates and the contributing factors. Data from a large randomised trial is sho...
Dr Tony Goldstone,  Imperial College London, UK Dr Tony Goldstone, Imperial College London, UK
Channel: www.ecancer.tv
Length: 0
Date: July 22, 2010
Dr Goldstone talks about the UKALL trials investigating treatment options for patients with ALL. These trials have compared allograft, the use of ...
Page: 10 of 30Previous Page67891011121314Next Page
 
MrWhy.com Special Offers
1
2
3
4
5
 
About Us: About MrWhy.com | Advertise on MrWhy.com | Contact MrWhy.com | Privacy Policy | MrWhy.com Partners
Answers: Questions and Answers | Browse by Category
Comparison Shopping: Comparison Shopping | Browse by Category | Top Searches
Shop eBay: Shop eBay | Browse by Category
Shop Amazon: Shop Amazon | Browse by Category
Videos: Video Search | Browse by Category
Web Search: Web Search | Browse by Searches
Copyright © 2011 MrWhy.com. All rights reserved.